#100 Effectiveness of Seasonal Influenza Vaccine for Healthy Working-age Adults
CLINICAL QUESTION
Does the trivalent influenza vaccine (flu shot) prevent influenza or its complications in healthy working-age adults?
BOTTOM LINE
For healthy adults, the flu shot reduces influenza when vaccine is well-matched to circulating influenza strains (Numbers Needed to Treat (NNT)=12-37). When vaccine is poorly matched, effectiveness diminishes and may be similar to placebo. The flu shot has not been shown to affect hospitalizations in randomized trials and observational evidence that influenza vaccine decreases mortality is likely biased.
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
EVIDENCE
Meta-analysis of 22 randomized controlled trials (RCTs) of 51,724 predominantly healthy adults (16-65 years) randomized to inactivated trivalent influenza vaccine (flu shot) or placebo/no vaccination.1
- Influenza rates:
- Well-matched vaccine (matches ≥80% of circulating virus):
- Vaccine 1.2%, control 2.8%, NNT=63.
- Poor or uncertain vaccine match:
- Vaccine 1.2%, control 3.0%, NNT=56.
- Well-matched vaccine (matches ≥80% of circulating virus):
- Number of days ill decreased by ~1/2 day when vaccine matched but increased by ~2/3 day when vaccine did not match.
- The flu shot did not affect hospitalization (assessed in two trials) or pneumonia rates (one trial), and mortality rates were not reported.
- Systemic adverse effects (fever, myalgias): Vaccine 23%, placebo 15%
- Limitations: Most studies short term (one influenza season), many evaluated health care workers, children, or influenza epidemics 30 years ago.
- 1,191 American factory workers (mean age 44, ~80% males), over two influenza seasons.
- Influenza rates:
- Well-matched vaccine: Vaccine 1.4%, placebo 10.2%, NNT=12.
- Poor vaccine match: No statistical difference.
- The flu shot includes three influenza strains, updated annually to match predicted strains. In Canada, vaccine was well-matched in only seven of the last 14 years.4
- Observational evidence demonstrating that the flu shot reduces hospitalizations and mortality appears biased by healthier patients more often choosing vaccination. 5-7
- Canadian and American national immunization committees encourage universal influenza vaccinations.8,9
Latest Tools for Practice
#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
#377 How to slow the flow IV: Combined oral contraceptives
In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
#376 Testosterone supplementation for cis-gender men: Let’s (andro-)pause for a moment (Update)
What are the benefits and harms of testosterone supplementation in healthy cis-gender men or those with age-related low testosterone?
